Newborn screening for neurodevelopmental diseases: Are we there yet?
Wendy K. Chung(Oregon Health & Science University), Zhanzhi Hu(Columbia University), Annamarie Saarinen(Saint Paul & Minnesota Foundation), Jonathan S. Berg(University of North Carolina at Chapel Hill), Walter E. Kowtoniuk(Third Way), Amy Gaviglio(Centers for Disease Control and Prevention), Steven E. Brenner(University of California, Berkeley), Yufeng Shen(Columbia University Irving Medical Center), Jeffrey R. Botkin(University of Utah), Elliott H. Sherr(University of California, San Francisco), Michele A. Lloyd-Puryear(National Institutes of Health), Mustafa Şahin(Boston Children's Hospital), Kyle B. Brothers(University of Louisville), Jeffrey P. Brosco, Colleen Olson(New York University), Michael S. Watson(American College of Medical Genetics), Robert J. Currier(California Department of Public Health)
American Journal of Medical Genetics Part C Seminars in Medical Genetics
June 1, 2022
Cited by 28
Related Papers
WebLogo: A Sequence Logo Generator: Figure 1
|Genome Research|2004|13k
The support of human genetic evidence for approved drug indications
|Nature Genetics|2015|1.8k
The Genome of the Sea Urchin <i>Strongylocentrotus purpuratus</i>
|Science|2006|1.2k
Pediatric Pulmonary Hypertension
|Circulation|2015|1.1k